Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2017) 49 EP985 | DOI: 10.1530/endoabs.49.EP985

ECE2017 Eposter Presentations: Pituitary and Neuroendocrinology Pituitary - Clinical (145 abstracts)

Venous glucose levels, peak GH and peak cortisol during Insulin Tolerance Test using 0.15 UNITS/Kg and 0.1 UNITS/Kg body weight

Phillip Yeoh 1 , Ashley Grossman 2, , Shern L Chew 1 , Pierre Bouloux 3, , Bernad Khoo 3, , Paul Carroll 4, , Simon Aylwin 5, & Stephanie Baldweg 6,


1The London Clinic, London, UK; 2John Radcliffe Oxford, Oxford, UK; 3Royal Free Medical School, London, UK; 4Guys & St Thomas Hospital, London, UK; 5Kings College Hospital, London, UK; 6UCLH Hospitals, London, UK.


Insulin Tolerance Test (ITT) is a procedure commonly done by Endocrine Specialist Nurse in endocrine department. We look at over 120 ITT results done in 2 endocrine centres using Insulin Actrapid 0.15 UNITS/kg and 0.10 UNITS/kg dose plotting the glucose levels at 30, 45 and 60 min. We also look at peak GH and peak cortisol on each of these groups.

Aims: We wanted to know how many percentage of patients achieving hypoglycaemia below 0.5 mmol/l, 0.5–1.0 mmol/l, 1.1–1.5 mmol/l, 1.6–2.0 mmol/l and above 2.0 mmol/l. We also look at percentage of peak GH response achieving over 9 microgram/l, between 8–9 microgram/l and below 8 microgram/l. In the peak cortisol response, we looked at results over 550 nmol/l; 500–550 nmol/l; 450–500 nmol/l; 400–450 nmol/l and below 400 nmol/l. Within these data, we also look at a small groups of results for patients’ using 0.15 UNITS/kg as repeat dose and repeat ITT using the lower dose to compare if these are difference in these markers.

Summary: We are unable to draw summary at the moment as well still got 30 data to go through.

Volume 49

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.